Mark Edwards
Follow
Get notifications in MyBN when activity occurs.
Mark Edwards
Chief Financial Officer, Company Secretary / INOVIQ
Mark Edwards is a Chartered Accountant with over 14 years of experience in managing professional and non-professional finance staff; and all aspects of audit, financial reporting, analysis, internal control, financial leadership and management, corporate governance, investor relations and corporate transactions.
He also has experience in the retail, manufacturing, automotive, import and distribution sectors.
Mr Edwards spent 8 years as chief financial officer and company secretary of ASX-listed companies involved in multiple capital raisings, overseas expansion, business acquisition, business transformation and sales growth.
He was the chief financial officer and company secretary of Medical Developments International from June 2014 to November 2022 when he became chief financial officer and company secretary of INOVIQ.
He also has experience in the retail, manufacturing, automotive, import and distribution sectors.
Mr Edwards spent 8 years as chief financial officer and company secretary of ASX-listed companies involved in multiple capital raisings, overseas expansion, business acquisition, business transformation and sales growth.
He was the chief financial officer and company secretary of Medical Developments International from June 2014 to November 2022 when he became chief financial officer and company secretary of INOVIQ.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 291st | INOVIQ | 33% | 109% |
| 703rd | Frugl Group | 0% | -20% |
| 766th | Advanced Health Intelligence | -2% | -24% |
| 1615th | Nanollose | -60% | -21% |
| 1865th | Invex Therapeutics | -83% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 157th |  | INOVIQ | $1.6m |
| 172nd | | Frugl Group | $806k |
| 173rd | | Advanced Health Intelligence | $772k |
| 175th |  | Invex Therapeutics | $459k |
| 176th |  | Nanollose | $412k |
202 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Chief Financial Officer, Company Secretary, INOVIQ | 06 Oct 2022 |
| REMUNERATION UPDATE: Chief Financial Officer, Company Secretary, Medical Developments International | 13 Nov 2020 |
| NEW ROLE: Chief Financial Officer, Company Secretary, Medical Developments International | 03 Nov 2020 |
